- STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded accessThe FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.STAT · 13d ago↗ source
- CVS Caremark reaches settlement with FTC over insulin suit<figure><div><img src="https://imgproxy.divecdn.com/pNQvzj0_GetAxjrRFc5DxSkCrlrmkwi9gbx3E_Ny0UQ/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy01MzA3NDY2MDlfMW5Oc…BioPharma Dive · 13d ago↗ source
- STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last yearPrescription drugs purchased under a controversial government discount program amounted to $100 billion in 2025, a 22.8% increase from the previous year.